Therapeutics clinic

Biologics: new therapy for atopic dermatitis

THEONE PAPPS, Stephen Shumack

Figures

© adiano/stock.adobe.com
© adiano/stock.adobe.com

Abstract

The recent TGA approval of dupilumab, a biologic therapy aimed at targeting specific immune markers, provides new hope in the treatment of adults with moderate-to-severe atopic dermatitis.